Fingerpaint Group Acquires The MYND Group, Bolstering Market Access Capabilities

Fingerpaint Group, a collective of healthcare companies providing commercialization solutions, is expanding its market access capabilities with the acquisition of The MYND Group, a strategic market access marketing company specializing in pharmaceuticals and biologics.

The MYND Group will enhance Fingerpaint's market access strategy, research, and launch experience. Jonathan Magid will continue leading The MYND Group as Managing Director, reporting to Brannon Cashion, President of Specialty Services at Fingerpaint Group.

Fingerpaint Group has seen significant growth since partnering with private equity firm Knox Lane in 2020.